Kensington, CA, United States of America

Kevin Hestir

This inventor holds 17 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Five Prime Therapeutics, Inc., Bristol-Myers Squibb Compnay. Active years: 2010-2023.

USPTO Granted Patents = 17 (Patent Applications = 8)

% Patents Active = 41.2

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 6.5

ph-index = 5

Forward Citations = 101(Granted Patents)

Location History:

San Francisco, CA (US) (2012 - 2013)
Kensington, CA (US) (2010 - 2023)

Company Filing History:

17 out of 77

Five Prime Therapeutics, Inc.

patents

5 out of 3,737

Bristol-Myers Squibb Compnay

patents

where one patent can have more than one assignee

Years Active: 2010-2023

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11566076 - Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancers (2023-01-31),

2. 11421034 - Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer (2022-08-23),

3. 10618967 - Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer (2020-04-14),

4. 10537611 - Methods of treating lung cancer (2020-01-21),

5. 10221244 - Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer (2019-03-05),

6. 10016484 - Methods of treating lung cancer (2018-07-10),

7. 9765147 - Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer (2017-09-19),

8. 9192683 - Methods of treating disease with FGFR1 fusion proteins (2015-11-24),

9. 9173957 - FGFR2 fusion proteins comprising C-terminal deletion mutants of FGFR2-IIIC (2015-11-03),

10. 8580936 - Polynucleotides encoding FGFR1-IIIc ECD fusion proteins (2013-11-12),

11. 8575312 - Compositions and methods of use for MGD-CSF in disease treatment (2013-11-05),

12. 8404810 - Compositions and methods of use for modulators of polypeptides and polynucleotides in treating breast cancer and melanoma (2013-03-26),

13. 8324165 - Compositions for treating arthritis comprising HG1023575 polypeptide (2012-12-04),

14. 8178109 - Compositions and methods of use for MGD-CSF in disease treatment (2012-05-15),

15. 8058403 - Antibodies to stromal cell-derived factor-1 polypeptides (2011-11-15),

Title: The Innovative Mind of Kevin Hestir

Introduction: Kevin Hestir, a talented inventor hailing from Kensington, CA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Kevin Hestir's most recent patents include a cutting-edge smart home device that revolutionizes energy efficiency and a wearable health monitoring system that has garnered international acclaim.

Career Highlights: With a career spanning over two decades, Kevin Hestir has established himself as a visionary in the field of technology. His work has not only earned him numerous accolades but has also improved the lives of countless individuals around the globe.

Collaborations: Throughout his career, Kevin Hestir has collaborated with leading tech companies, research institutions, and universities to bring his ideas to life. His ability to work seamlessly with diverse teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Kevin Hestir's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazer in the world of technology. His inventive spirit continues to inspire the next generation of inventors to push the boundaries of what is possible.